Quantifying the Persistence of Metabolic Adaptation and Weight Regain Following Extreme Weight Loss
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02544009 |
Recruitment Status :
Completed
First Posted : September 9, 2015
Last Update Posted : February 8, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Background:
Many people regain the weight they lose through diet and exercise. This might happen because the weight loss slows their metabolism. This slowing is called metabolic adaptation. It may cause people to regain weight if they do not keep up high levels of exercise or major caloric restrictions. Researchers want to find the long-term effects of metabolic adaptation in the previous Biggest Loser study participants. They hope to learn the body s response to lifestyle changes that result in weight loss. They also want to see if certain changes can lead to longer-term success in maintaining weight loss.
Objectives:
To better understand the long-term metabolic changes caused by rapid weight loss achieved through diet restriction and vigorous physical activity.
Eligibility:
Former Biggest Loser research study participants (Protocol No. PBRC29008).
Design:
Participants will be screened with a phone interview.
This study has 3 phases.
Phase 1 will last at least 3 weeks. Participants will receive a physical activity monitor and wireless scale. These will send their daily weight and activity back to NIH.
In Phase 2, participants will stay at NIH for 3 days. Their metabolism will be measured through:
Their activity monitor
Urine samples and daily body weight
Medical review and physical exam
Fasting for 12 hours each night for a blood draw the following morning
DEXA: a low-dose x-ray of the body
BIS: Electrodes on the hand/wrist and foot/ankle measure body water content.
Phase 3 will last at least 3 weeks. Participants will:
Continue to monitor their daily weight and activity
Collect urine samples and send them back to NIH
Condition or disease |
---|
Energy Expenditure |
Study Type : | Observational |
Actual Enrollment : | 15 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Quantifying Weight Regain and the Persistence of Metabolic Adaptation Following Extreme Weight Loss |
Study Start Date : | September 5, 2015 |
Actual Primary Completion Date : | May 19, 2016 |
Actual Study Completion Date : | May 19, 2016 |

Group/Cohort |
---|
1
16 subjects who previously participated in the Biggest Loser study
|
- Measure body composition and REE several years after completion of The Biggest Loser intervention. Metabolic adaptation will be calculated as the difference between the measured REE and the REE predicted from linear regression analysis of baseli... [ Time Frame: 2 weeks ]The primary analysis will use a t-test to test the null hypothesis that this difference is equal to zero. Secondary analyses will explore predictors of metabolic adaptation.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
- INCLUSION CRITERIA:
- 16 subjects who previously participated in the Biggest Loser study (Pennington Biomedical Research Center protocol no. PBRC29008).
- Written informed consent
EXCLUSION CRITERIA:
- Volunteers unwilling or unable to give informed consent.
- Women who are pregnant or breastfeeding cannot participate in the study. A pregnancy test will be performed during the first day of the inpatient visit. If the pregnancy test is positive, the subject cannot continue to participate in the study.
- Subjects with implantable cardio-defibrillator or pacemaker may not participate in the bioelectric impedance spectroscopy (BIS) testing portion of the study.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02544009
United States, Maryland | |
National Institutes of Health Clinical Center, 9000 Rockville Pike | |
Bethesda, Maryland, United States, 20892 |
Principal Investigator: | Kevin Hall, Ph.D. | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
ClinicalTrials.gov Identifier: | NCT02544009 |
Other Study ID Numbers: |
150192 15-DK-0192 |
First Posted: | September 9, 2015 Key Record Dates |
Last Update Posted: | February 8, 2021 |
Last Verified: | July 20, 2020 |
Energy Expenditure Obesity Behavioral Weight Loss Treatment |
Weight Loss Body Weight Changes Body Weight |